Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Raggi

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
The American Journal of Pathology|July 28, 2019
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic CholangiocarcinomaChiara Raggi, Karim Fiaccadori, Mirella Pastore, et al.
Gut|September 1, 2025
Immunosuppressive contribution of tumour-infiltrating B cells in human intrahepatic cholangiocarcinoma and their role in chemoimmunotherapy outcomeGiulia Milardi, Barbara Franceschini, Chiara Camisaschi, et al.
Nature Reviews. Gastroenterology & Hepatology|April 21, 2016
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)Jesus M Banales, Vincenzo Cardinale, Guido Carpino, et al.
JHEP Reports : Innovation in Hepatology|October 21, 2024
Altered fatty acid metabolism rewires cholangiocarcinoma stemness featuresGiulia Lori, Mirella Pastore, Nadia Navari, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 27, 2024
Ganglioside GD2 Contributes to a Stem-Like Phenotype in Intrahepatic CholangiocarcinomaAntonella Mannini, Mirella Pastore, Alessia Giachi, et al.
Nature Reviews. Gastroenterology & Hepatology|July 2, 2020
Cholangiocarcinoma 2020: the next horizon in mechanisms and managementJesus M Banales, Jose J G Marin, Angela Lamarca, et al.
Nature Reviews. Gastroenterology & Hepatology|February 9, 2023
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevanceDiego F Calvisi, Luke Boulter, Javier Vaquero, et al.
Nature Reviews. Gastroenterology & Hepatology|December 10, 2025
Cholangiocarcinoma 2026: status quo, unmet needs and prioritiesJesus M Banales, Pedro M Rodrigues, Silvia Affò, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
The American Journal of Pathology|July 28, 2019
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic CholangiocarcinomaChiara Raggi, Karim Fiaccadori, Mirella Pastore, et al.
Gut|September 1, 2025
Immunosuppressive contribution of tumour-infiltrating B cells in human intrahepatic cholangiocarcinoma and their role in chemoimmunotherapy outcomeGiulia Milardi, Barbara Franceschini, Chiara Camisaschi, et al.
Nature Reviews. Gastroenterology & Hepatology|April 21, 2016
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)Jesus M Banales, Vincenzo Cardinale, Guido Carpino, et al.
JHEP Reports : Innovation in Hepatology|October 21, 2024
Altered fatty acid metabolism rewires cholangiocarcinoma stemness featuresGiulia Lori, Mirella Pastore, Nadia Navari, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 27, 2024
Ganglioside GD2 Contributes to a Stem-Like Phenotype in Intrahepatic CholangiocarcinomaAntonella Mannini, Mirella Pastore, Alessia Giachi, et al.
Nature Reviews. Gastroenterology & Hepatology|July 2, 2020
Cholangiocarcinoma 2020: the next horizon in mechanisms and managementJesus M Banales, Jose J G Marin, Angela Lamarca, et al.
Nature Reviews. Gastroenterology & Hepatology|February 9, 2023
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevanceDiego F Calvisi, Luke Boulter, Javier Vaquero, et al.
Nature Reviews. Gastroenterology & Hepatology|December 10, 2025
Cholangiocarcinoma 2026: status quo, unmet needs and prioritiesJesus M Banales, Pedro M Rodrigues, Silvia Affò, et al.
Pageof 6